Contemporary OB/GYN week in review: STI epidemic, HPV vaccine, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: STI epidemic, HPV vaccine, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, January 1 - Friday, January 5, 2023), and click each link to read and watch anything you may have missed.
1.) Behavioral shifts driving STI epidemic: A deep dive
A recent study explores how changing sexual behaviors influence rising sexually transmitted infection rates, underscoring the need for comprehensive prevention strategies.
Click here for the full article.
2.) Long-term HPV vaccine efficacy: 10-year study reveals protection in youth
A decade-long study confirms significant protection against human papillomavirus remains in patients vaccinated up to age 20, reinforcing the World Health Organization's single-dose vaccination recommendation for adolescents.
Click here for the full article.
3.) The clinical takeaways of the RSV immunizations
The panel discusses the importance of discussing the immunizations with patients now, as well as the value of them in future seasons.
Click here for the full article.
4.) FDA warns of false positive HSV-2 test risks
The FDA emphasized the need for cautious herpes simplex virus type 2 serological testing, highlighting factors that increase the likelihood of false positives and urging adherence to CDC guidelines.
Click here for the full article.
5.) Digital health interventions reduce postpartum anxiety and depression
A recent meta-analysis reveals that digital health interventions significantly alleviate symptoms of postpartum anxiety and depression, underscoring their potential as accessible treatments for new mothers.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
Study finds reduced CIN3+ risk from early HPV vaccination
April 16th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
Read More
